From the product update email it does sound like Jon will remain involved with product development.
"We are in an exciting R&D Phase for Analytics and Outcomes offerings. Dr Bertman and Dr. Mosier are leading the charge and we are planning to add new clinical tools to AC that will assist you in managing and improving your patients' health. There will be more details published about this initiative in the near future."
